Procaps Group S.A. (PROC) Stock Analysis
DELISTED 2025
What happened to Procaps Group S.A. (PROC) stock?
Procaps Group S.A. (PROC) no longer trades on public markets. It was delisted in November 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2025
- Last recorded price (historical):
- $1.01 (last quote on record before the November 2025 delisting; historical, not a current quote)
P/E 2.40 means the share price is 2.40 times one year of earnings per share. Market cap $102M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Procaps Group S.A. (PROC). Procaps Group S.A. is a pharmaceutical company that develops, produces, and markets pharmaceutical solutions globally. The company specializes in branded prescription drugs and OTC consumer healthcare products across various therapeutic areas.
Last analyzed: May 31, 2026Procaps Group S.A. (PROC) Healthcare & Pipeline Overview
More about this archive record
Can I still buy PROC shares?
No. PROC stopped trading on public markets in November 2025, so the shares are not available through a broker. Anything you see quoted for PROC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PROC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Procaps Group S.A.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.